
Cefarka 500mg Injection
Marketer
Mediarka Lifesciences Pvt Ltd
Salt Composition
Ceftriaxone (500mg)
Overview Cefarka 500mg Injection
Cephalosporin-based antibiotic Cefarka 500mg Injection combats bacterial infections throughout the body. Its applications encompass diverse infections affecting the brain (meningitis), lungs (pneumonia), ears, urinary tract, skin and soft tissues, bones and joints, blood, and heart. Prophylactic use is also indicated for surgical infection prevention. Administered intravenously (drip) or via intramuscular/intravenous injection by a healthcare professional, dosage is determined individually. Adherence to the prescribed regular dosing schedule is crucial; premature cessation risks infection recurrence or exacerbation. Common side effects may comprise diarrhea, rash, altered liver function test results, and atypical blood cell counts (e.g., elevated eosinophils, leukopenia, thrombocytopenia). Transient injection site reactions (redness, pain) are possible. While usually mild, persistent or bothersome side effects warrant medical attention. Prior to treatment, disclose any antibiotic allergies, kidney or liver impairments, and all concurrent medications to your doctor, as drug interactions may occur.
Uses of Cefarka 500mg Injection
Combating Bacterial Infections
Major Benefits of Cefarka 500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Cefarka 500mg Injection:
- Diarrhea
- Abnormal liver function tests
- Rash
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count
- Low blood platelets
How to use Cefarka 500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Cefarka 500mg Injection works:
Cefarka 500mg injection is a bacterial-killing antibiotic that works by disrupting bacterial cell wall synthesis, a process essential for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Cefarka 500mg Injection use alongside alcohol consumption poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Cefarka 500mg Injection is considered safe. Research largely indicates minimal or absent risk to the fetus.
Breast feedingCAUTION
Administering Cefarka 500mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Cefarka 500mg Injection could lead to drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects manifest.
KidneySAFE IF PRESCRIBED
Cefarka 500mg Injection can be administered to patients with kidney disease without altering the dosage. However, disclosure of any pre-existing renal impairment to the prescribing physician is advised.
LiverCAUTION
Exercise caution when administering 500mg Cefarka injections to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alterations for Cefarka 500mg Injection are not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cefarka 500mg Injection :
Omit a Cefarka 500mg Injection dose? Seek your physician's advice.
Facts to Know About Cefarka 500mg Injection
| Label | Value |
|---|---|
| Chemical Category | Extended-Spectrum Cephalosporins (Generations 3 & 4) |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
